All news from Immuno Haematology & Blood Transfusion

Breast Cancers Grow By Recruiting Cells From Bone Marrow

Researchers in Israel have discovered that breast tumors can boost their growth by recruiting stromal cells originally formed in the bone marrow.  The study, which will be published November 23 in the Journal of Experimental Medicine, reveals that the recruitment of bone marrow-derived fibroblasts lowers the odds of surviving breast cancer, but suggests that targeting these cells could be an effective way of treating the disease.

Health Surrogates For Older Adults And Care Preferences

When it comes to making health decisions for an older adult, what health surrogates do not know can be harmful, according to new research. While 75% of surrogates feel extremely confident in their knowledge of a loved one's preferences, only 21% of them actually know what the older patient would want in the event of a serious illness, the researchers said.

Undiagnosed Diabetes: Threat in Bangladesh

Diabetes is not only a health crisis but also a burden on the health sector and the economy as it causes devastating personal suffering and drives families into poverty. The developed countries with hefty health expenditure of gross domestic product are struggling to meet the cost of diabetes care. The reality is the financial burden will continue to increase, thanks to the growing number of people developing diabetes.

Irdai Panel: Diseases Contracted After Health Policy Purchase Should be Covered

Chronic diseases like Alzheimer's, Parkinson's, AIDs / HIV infection and Morbid obesity should be covered under medical coverage if a person contracts such ailments after buying a health insurance policy, according to recommendations of a panel set up by Irdai. The working group has also suggested a list of 17 diseases, including chronic kidney disease, Hepatitis B, Alzheimer's, epilepsy and HIV & AIDS, which could be excluded from health insurance polices

Valvular Heart Disease: Role of Impaired Cellular Force Transmission

About three per cent of the world's population is affected by valvular heart diseases. It is also the most common cause of heart surgery, as no drug-based treatment is available. Recent research has shed light on the molecular mechanism on the valvular disease that is caused by a genetic mutation in Filamin gene. The result of the research will help to further investigate the mechanism by which the medical condition progress and to develop new treatments. The study was published in the journal Structure